{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:10:57Z","timestamp":1792174257521,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.radonc.2021.09.006","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T01:28:18Z","timestamp":1631842098000},"page":"50-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boost"],"prefix":"10.1016","volume":"164","author":[{"given":"D.","family":"Franceschini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2282-9894","authenticated-orcid":false,"given":"A.","family":"Fogliata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Spoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Dominici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Lo Faro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Franzese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Comito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Lobefalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Reggiori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Cozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sagona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Scorsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.radonc.2021.09.006_b0005","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.radonc.2021.09.006_b0010","unstructured":"NCCN guidelines Version 1.2021."},{"key":"10.1016\/j.radonc.2021.09.006_b0015","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2021.09.006_b0020","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1470-2045(06)70699-4","article-title":"Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: Long-term results of a randomised trial","volume":"7","author":"Owen","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2021.09.006_b0025","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1470-2045(08)70077-9","article-title":"The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial","volume":"9","author":"START Trialists\u2019 Group","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2021.09.006_b0030","first-page":"1098","article-title":"The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial","author":"START Trialists\u2019 Group","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2021.09.006_b0035","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2021.09.006_b0040","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Murray Brunt","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2021.09.006_b0045","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.radonc.2018.04.009","article-title":"ESTRO-ACROP guideline: Interstitial multi-catheter breast brachytherapy as Accelerated Partial Breast Irradiation alone or as boost - GEC-ESTRO Breast Cancer Working Group practical recommendations","volume":"128","author":"Strnad","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.09.006_b0050","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.prro.2016.09.007","article-title":"Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement","volume":"7","author":"Correa","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2021.09.006_b0055","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1748-717X-7-145","article-title":"Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments","volume":"7","author":"Scorsetti","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2021.09.006_b0060","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1200\/JCO.2006.09.1041","article-title":"Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue","volume":"25","author":"Formenti","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2021.09.006_b0065","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2021.09.006_b0070","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1118\/1.3598442","article-title":"Planning strategies in volumetric modulated arc therapy for breast","volume":"38","author":"Nicolini","year":"2011","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2021.09.006_b0075","first-page":"1323","article-title":"Various aspects of \u2018quality of life\u2019 and the treatment of patients with breast cancer","volume":"132","author":"van Dam","year":"1998","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.radonc.2021.09.006_b0080","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-016-0701-z","article-title":"Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results","volume":"11","author":"De Rose","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2021.09.006_b0085","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1470-2045(14)71156-8","article-title":"Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial","volume":"16","author":"Bartelink","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2021.09.006_b0090","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1200\/JCO.20.00650","article-title":"Accelerated partial-breast irradiation compared with whole-breast irradiation for early breast cancer: long-term results of the randomised phase III APBI-IMRT-Florence trial","volume":"38","author":"Meattini","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2021.09.006_b0095","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/S0140-6736(19)32514-0","article-title":"Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: A randomised, phase 3, equivalence trial","volume":"394","author":"Vicini","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2021.09.006_b0100","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ijrobp.2020.12.005","volume":"109","author":"H\u00f6rner-Rieber","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.09.006_b0105","first-page":"4749","article-title":"Adjuvant hypofractionated radiotherapy with weekly concomitant boost for women with early breast cancer: the clinical experience at Genoa university","volume":"30","author":"Corvo","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1016\/j.radonc.2021.09.006_b0110","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.ijrobp.2014.03.036","article-title":"Prone breast intensity modulated radiation therapy: 5-year results","volume":"89","author":"Osa","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.09.006_b0115","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-017-1020-4","article-title":"Ten-year results of accelerated hypofractionated adjuvant whole-breast radiation with concomitant boost to the lumpectomy cavity after conserving surgery for early breast cancer","volume":"34","author":"Cante","year":"2017","journal-title":"Med Oncol"},{"key":"10.1016\/j.radonc.2021.09.006_b0120","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1415340","article-title":"Regional nodal irradiation in early-stage breast cancer","volume":"373","author":"Whelan","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2021.09.006_b0125","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.clbc.2020.06.005","article-title":"Hypofractionated whole breast irradiation and simultaneously integrated boost in large-breasted patients: long-term toxicity and cosmesis","volume":"20","author":"De Rose","year":"2020","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.radonc.2021.09.006_b0130","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1080\/0284186X.2018.1497294","article-title":"A comparison of conventional and dynamic radiotherapy planning techniques for early-stage breast cancer utilizing deep inspiration breath-hold","volume":"57","author":"Vikstr\u00f8m","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2021.09.006_b0135","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijrobp.2012.09.001","article-title":"Second solid cancers after radiation therapy: a systematic review of the epidemiologic studies of the radiation dose-response relationship","volume":"86","author":"Berrington de Gonzalez","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.09.006_b0140","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.ijrobp.2008.02.040","article-title":"dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study","volume":"72","author":"Stovall","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.09.006_b0145","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/02841860802657227","volume":"48","author":"Johansen","year":"2009","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2021.09.006_b0150","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ijrobp.2017.10.040","article-title":"Critical appraisal of the risk of secondary cancer induction from breast radiation therapy with volumetric modulated arc therapy relative to 3D conformal therapy","volume":"100","author":"Fogliata","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814021067268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814021067268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:18:30Z","timestamp":1759123110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814021067268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":30,"alternative-id":["S0167814021067268"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2021.09.006","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boost","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2021.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}